BIO-key International (NASDAQ:BKYI – Get Free Report) and JFrog (NASDAQ:FROG – Get Free Report) are both technology companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends and valuation.
Institutional and Insider Ownership
26.5% of BIO-key International shares are owned by institutional investors. Comparatively, 85.0% of JFrog shares are owned by institutional investors. 4.0% of BIO-key International shares are owned by insiders. Comparatively, 11.8% of JFrog shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Valuation & Earnings
This table compares BIO-key International and JFrog”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| BIO-key International | $6.09 million | 0.61 | -$7.16 million | ($4.11) | -0.63 |
| JFrog | $531.84 million | 21.21 | -$71.82 million | ($0.37) | -247.24 |
BIO-key International has higher earnings, but lower revenue than JFrog. JFrog is trading at a lower price-to-earnings ratio than BIO-key International, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent ratings and recommmendations for BIO-key International and JFrog, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| BIO-key International | 1 | 1 | 0 | 0 | 1.50 |
| JFrog | 1 | 1 | 21 | 0 | 2.87 |
JFrog has a consensus target price of $109.48, suggesting a potential upside of 19.67%. Given JFrog’s stronger consensus rating and higher possible upside, analysts clearly believe JFrog is more favorable than BIO-key International.
Profitability
This table compares BIO-key International and JFrog’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| BIO-key International | -50.01% | -67.31% | -40.28% |
| JFrog | -7.35% | -2.71% | -1.80% |
Risk & Volatility
BIO-key International has a beta of 0.4, meaning that its stock price is 60% less volatile than the S&P 500. Comparatively, JFrog has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500.
Summary
JFrog beats BIO-key International on 12 of the 14 factors compared between the two stocks.
About BIO-key International
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.
About JFrog
JFrog Ltd. provides end-to-end hybrid software supply chain platform in the United States, Israel, India, and internationally. The company offers JFrog Artifactory, a package repository that allows teams and organizations to store, update, and manage their software packages; JFrog Curation that functions as a guardian outside the software development pipeline, controlling the admission of packages into an organization, primarily from open source or public repositories; JFrog Xray, which scans JFrog Artifactory to secure all software packages; JFrog Advanced Security, an optional add-on for select JFrog subscriptions; and JFrog Distribution that provides software package distribution. It also provides JFrog Artifactory Edge that utilizes and leverages metadata from JFrog Artifactory to facilitate the transfer of the incremental changes in software packages from their previous versions; JFrog Mission Control, a platform control panel that provides a view of moving pieces of an organization’s software supply chain workflow; JFrog Insight, a DevOps intelligence tool; JFrog Connect, a device management solution that allows companies to manage software updates and monitor performance in IoT device fleets; and JFrog Pipelines, a continuous integration and delivery tool for automating and orchestrating the movement of software packages. In addition, the company provides JFrog Pro that provides access to the universal version of JFrog Artifactory and ongoing updates, upgrades, and bug fixes; JFrog Pro X, a self-hosted-only subscription; JFrog Enterprise X, which offers cluster configuration, federated repositories, multi-region replication, larger enterprise-scale deployments, service-level agreement support, and deeper security; and JFrog Enterprise Plus, a full platform subscription option. It serves technology, financial services, retail, healthcare, and telecommunications organizations. JFrog Ltd. was incorporated in 2008 and is headquartered in Sunnyvale, California.
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.
